Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011860 (
type 2 diabetes
)
57,723
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Insulin promotes hepatic apolipoprotein B100 (apoB100) degradation, whereas insulin resistance is a major cause of hepatic apoB100/triglyceride overproduction in
type 2 diabetes
. The cellular trafficking receptor
sortilin 1
(
Sort1
) was recently identified to transport apoB100 to the lysosome for degradation in the liver and thus regulate plasma cholesterol and triglyceride levels. Genetic variation of SORT1 was strongly associated with cardiovascular disease risk in humans. The major goal of this study is to investigate the effect and molecular mechanism of insulin regulation of
Sort1
. Results showed that insulin induced
Sort1
protein, but not mRNA, in AML12 cells. Treatment of PI3K or AKT inhibitors decreased
Sort1
protein, whereas expression of constitutively active AKT induced
Sort1
protein in AML12 cells. Consistently, hepatic
Sort1
was down-regulated in diabetic mice, which was partially restored after the administration of the insulin sensitizer metformin. LC-MS/MS analysis further revealed that serine phosphorylation of
Sort1
protein was required for insulin induction of
Sort1
in a casein kinase 2-dependent manner and that inhibition of PI3K signaling or prevention of
Sort1
phosphorylation accelerated proteasome-dependent
Sort1
degradation. Administration of a PI3K inhibitor to mice decreased hepatic
Sort1
protein and increased plasma cholesterol and triglyceride levels. Adenovirus-mediated overexpression of
Sort1
in the liver prevented PI3K inhibitor-induced
Sort1
down-regulation and decreased plasma triglyceride but had no effect on plasma cholesterol in mice. This study identified
Sort1
as a novel target of insulin signaling and suggests that
Sort1
may play a role in altered hepatic apoB100 metabolism in insulin-resistant conditions.
...
PMID:Insulin resistance induces posttranslational hepatic sortilin 1 degradation in mice. 2580 2